
Shares of Psyence Biomedical Ltd (NASDAQ:PBM) are surging Thursday morning following an announcement from the company and its strategic partner, PsyLabs.
What To Know: The companies reported the successful production of a high-purity, GMP-aligned Ibogaine Total Alkaloid extract, a significant milestone in the field of psychedelic medicine.